Cerebras Shorts Hit a Year High While an Activist Trims and Insiders Sell

CBRS short interest has climbed to its highest level in at least a year, rising 32% in a single week to roughly 21.1 million shares, even as the stock bounced 10% on Tuesday to close at $119.31.

The scale of the short buildup is the story this week. From late September through mid-October, borrowed shares held in a range of 14 to 16 million. Then, in the final days of last week, that figure jumped sharply: from 15.7 million on October 23 to 20.8 million on October 26 and 21.1 million by October 27. The 64% rise over the past month is the steepest sustained buildup since the company's May 2026 IPO. The ORTEX short score now sits at 68.1, its highest reading in the available history. For context, FINRA's fortnightly official count put short interest at 19.9 million shares as of October 15, already elevated before this week's acceleration. Despite the surge in borrowed shares, the lending market has not tightened meaningfully: availability runs at 83.9% and borrowing costs are a low 0.62%. That combination, a rapidly growing short position alongside ample and cheap borrow supply, points to deliberate conviction rather than a squeeze or a technical constraint.

The activist register adds a layer worth watching. Director Susan Lior, who first filed a Schedule 13D in May 2026, filed an amendment in August disclosing her stake had fallen to 4.3% from 5.2%. A 13D is an activist filing, the highest-signal disclosure in SEC registers, and a holder trimming below 5% may not be required to file again. The insider picture runs in the same direction. The COO, Dhiraj Mallick, sold approximately 150,000 shares across multiple transactions on September 29 at prices from $194 to $210, generating around $30 million in proceeds. All of those sales were conducted under a pre-arranged 10b5-1 plan, which reduces their informational content somewhat, though the size and timing, at prices roughly 65% above where the stock trades today, is noted. The 90-day net insider position across all reported transactions stands at minus 549,820 shares, with a net value of negative $112.8 million. Stakes in the activist register are disclosed on an event-driven basis around the 5% threshold and reflect positions as last filed.

The Street remains broadly positive despite the price drop. The consensus is Buy, with a mean target of $282.55 against a current price of $119.31, implying significant return potential on paper. TD Cowen cut its target to $175 from $275 on October 19 while keeping a Buy rating, a meaningful reduction from a firm tracking the name closely. That move followed last quarter's post-earnings slide: the stock fell 1.6% the day after the August 12 results and then dropped a further 8.1% over the following five days. The September 22 print produced an almost identical pattern: minus 1.6% on the day, minus 6.5% over the following week. The bear case centres on customer concentration, with OpenAI accounting for the bulk of a $25 billion revenue pipeline, and the challenge of competing against NVIDIA with a hardware product described as expensive for inference workloads. The bull case rests on the CS-4's claimed performance advantage and a revenue trajectory forecast to more than triple next year. The PE multiple has compressed sharply, down 116 points over the past 30 days to 123.9x, and the price-to-book has fallen by 2.1x over the same period to 3.3x. Those moves reflect the 42% one-month price decline rather than a fundamental re-rating.

FMR LLC remains the largest institutional holder with 12.1% of shares, though its own 13G filing shows the stake has fallen from 46.6% to 25.7% as a percentage of class since it first disclosed in June 2026, a substantial reduction as the float has grown post-IPO. Coatue, Atreides and Bradley Gerstner's Altimeter each held stakes above 6% as of their most recent filings in August and June, though those figures predate the recent price move by several weeks.

The next earnings date is November 12. Given back-to-back post-results sell-offs and a short position at its highest recorded level, the question heading into that print is whether the revenue concentration in the OpenAI relationship is narrowing, and whether any new enterprise names appear in the customer disclosures.